Paradigm Biopharmaceuticals has selected Advanced Clinical as the clinical research organisation (CRO) to support its pivotal ...
Paradigm Biopharmaceuticals has selected Advanced Clinical as the preferred clinical research organisation for the phase III ...
GlobalData on MSN4d
MSD commences Phase III trial of DLBCL treatmentMSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...
Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you should know.
GlobalData on MSN4d
Replicate’s rabies vaccine rivals Bavarian Nordic’s RavAlert at Phase IThe US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...
Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...
GH Research PLC announced positive results from a Phase 2b clinical trial of GH001, an inhalable treatment for treatment-resistant depression (TRD), demonstrating a significant placebo-adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback